Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29955983 | 0.81 | ABCC4 (0.35) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL20917199 | 0.78 | MAPT (0.33) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL11027834 | 0.78 | LSS (0.35) | ALDH1A1GAA | |
| SCHEMBL22458995 | 0.78 | FAAH (0.36) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL11027832 | 0.78 | LSS (0.35) | ALDH1A1GAA | |
| SCHEMBL23529588 | 0.77 | KMT2A (0.31) | KMT2A | |
| SCHEMBL3628936 | 0.77 | HPGD (0.35) | ALDH1A1TSHRKMT2A | |
| SCHEMBL11029083 | 0.76 | TSHR (0.36) | ALDH1A1TSHR | |
| SCHEMBL7499380 | 0.76 | LMNA (0.32) | MAPTABCC4ALDH1A1LMNA | |
| SCHEMBL11029073 | 0.76 | TSHR (0.36) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1500477-A | Quick result aerosol with plant aroma and its preparation | 丛繁滋 | 2004-06-02 | — | — | CN | claimed |
| US-11820864-B2 | Aqueous polyglycidol synthesis with ultra-low branching | VANDERBILT UNIVERSITY (US) | 2023-11-21 | — | — | US | disclosed |
| US-11807726-B2 | Method of crosslinking glycosaminoglycans | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-11-07 | — | — | US | disclosed |
| US-20230312779-A1 | Method for Multicolor Lithography Using Mechanical Force | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-10-05 | — | — | US | disclosed |
| US-20180134843-A1 | AQUEOUS POLYGLYCIDOL SYNTHESIS WITH ULTRA-LOW BRANCHING | VANDERBILT UNIVERSITY | 2018-05-17 | — | — | US | disclosed |
| US-20180125983-A1 | Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures | UNIV VANDERBILT (US) | 2018-05-10 | — | — | US | disclosed |
| US-9757463-B2 | Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures | VANDERBILT UNIVERSITY (US) | 2017-09-12 | — | — | US | disclosed |
| US-9745419-B2 | Aqueous polyglycidol synthesis with ultra-low branching | VANDERBILT UNIVERSITY (US) | 2017-08-29 | — | — | US | disclosed |
| US-20160367525-A1 | USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION | ACCENDATECH (CN) | 2016-12-22 | — | — | US | disclosed |
| US-20160206743-A1 | Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures | VANDERBILT UNIVERSITY | 2016-07-21 | — | — | US | disclosed |
| US-8426527-B2 | Crosslinkable fluororubber composition and crosslinked rubber article | ASAHI GLASS COMPANY, LIMITED (JP) | 2013-04-23 | — | — | US | disclosed |
| US-20120202950-A1 | CROSSLINKABLE FLUORORUBBER COMPOSITION AND CROSSLINKED RUBBER ARTICLE | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8093427-B2 | Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-01-10 | — | — | US | disclosed |
| US-20110306668-A1 | CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-12-15 | — | — | US | disclosed |
| US-20110306668-A1 | CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-12-15 | — | — | US | disclosed |
| CN-1572335-A | Self-Service respiratory vaccination instrument for SARS infectious disease | CONG FANZI (CN) | 2005-02-02 | — | — | CN | disclosed |
| CN-1394596-A | Peroral and pernasal administration compound, spray and auxiliary preparation and its preparation method | CONG FANZI (CN) | 2003-02-05 | — | — | CN | disclosed |
| EP-0548774-B1 | Process for producing a lactone or an ester | SUMITOMO CHEMICAL CO (JP) | 2000-03-15 | — | — | EP | disclosed |
| US-5405974-A | Reacting a ketone, oxygen, an aromatic aldehyde using an aromatic solvent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0548774-A1 | Process for producing a lactone or an ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180125983-A1 | Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures | STT3A, STT3B, B3GAT3 | MAPT 175/4885ABCC4 3591/4885ALDH1A1 4091/4885 |
| US-20160206743-A1 | Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures | STT3A, STT3B, B3GAT3 | MAPT 175/4885ABCC4 3591/4885ALDH1A1 4091/4885 |
| US-20160367525-A1 | USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION | MCL1, TNF, LSS | MAPT 4674/4885ABCC4 285/4885ALDH1A1 70/4885 |
| US-20110306668-A1 | CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID | CYP4F2, ACR, CYP4F3 | MAPT 3769/4885ABCC4 1232/4885ALDH1A1 48/4885 |
| US-11807726-B2 | Method of crosslinking glycosaminoglycans | CD44, HPSE, CSGALNACT1 | MAPT 4850/4885ABCC4 1755/4885ALDH1A1 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.